Federal and state laboratory regulations are meant to ensure accuracy and safety, but without the expert input of pathologists, new rules may either fail to achieve those goals or place undue burden on the profession.
The CAP advocates to ensure regulations protect patients without overburdening pathologists and laboratories. This includes advocating for a sensible public-private oversight approach, ensuring the quality and accuracy of laboratory-developed tests (LDTs). Our legislative proposals use a stratified approach, effectively balancing regulations by the FDA and CMS without stifling innovation or patient access to LDTs. Learn more about our principles for the oversight of LDTs.
Find out about other key pathology issues and the CAP’s engagement: